Professor Marcus Franz
Cardiovascular Center Rotenburg an der Fulda, Rotenburg an der Fulda (Germany)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Real-world outcome and long-term survival analysis after trans-catheter aortic valve implantation (TAVI) - does age matter?
Event: ESC Congress 2023
Topic: Aortic Valve Stenosis
Session: Old and new predictors of outcome after TAVI
Successful treatment of pulmonary hypertension and right heart failure by antibody-based functional blocking of the extra-domain A of fibronectin in a preclinical animal model
Event: ESC Congress 2023
Topic: Cardiovascular Pharmacotherapy
Session: Improving outcomes in heart failure: bench to bedside
Prognostic relevance of mitral regurgitation at different follow-up timepoints after transcatheter aortic valve implantation (TAVI): implications for therapeutic decision making?
Event: ESC Congress 2022
Topic: Intervention
Session: Challenges in transcatheter aortic valve intervention
Tricuspid regurgitation and atrial fibrillation at baseline independently predict two-year survival after transcatheter aortic valve implantation (TAVI)
Event: ESC Congress 2022
Topic: Intervention
Session: Challenges in transcatheter aortic valve intervention
Chronic cardiac allograft rejection after heterotopic rat heart transplantation: ed-a but not ed-b domain containing fibronectin as novel serum biomarker of cardiac allograft vasculopathy
Event: ESC Congress 2019
Topic: Heart Transplantation
Session: Heart Failure Basic Science
Pre-existing depression significantly improves after transcatheter aortic valve implantation (TAVI): analysis of long-term effects and screening for novel biomarkers
Event: ESC Congress 2019
Topic: Epidemiology, Prognosis, Outcome
Session: Aortic valve interventions
Heart failure in aortic stenosis: extra-valvular cardiac damage according to the novel 2017 staging classification is differentially reflected by certain biomarkers of cardiovascular remodelling
Event: Heart Failure 2019
Topic: Pathophysiology and Mechanisms
Session: Valvular Heart Disease
Serum levels of fetal tenascin-C variants as novel biomarkers reflecting vascular remodeling and right ventricular dysfunction in pulmonary hypertension
Event: ESC Congress 2017
Topic: Chronic pulmonary hypertension
Session: Pulmonary hypertension, congenital and acquired
Pharmacological inhibition of arginase activity in a rat model of monocrotaline-induced pulmonary hypertension.
Event: ESC Congress 2017
Topic: Treatment of hypertension
Session: Hypertension drug treatment
ESC 365 is supported by
